Swiss Society
of Cannabis in Medicine

Research

We support the clinical and basic research for the medicalization of cannabis and cannabinoids.

Data Base

A data base should allow us to evaluate and validate the different treatments, indications and therapy experiences. Consequently, this is the basis for the elaboration of therapy recommendations and guidelines.

Professional Informations and Therapy Recommendations

Evidence- and experience-based therapy recommendations should support health professionals in practice.

Patient Informations

In cooperation with patient organizations we elaborate professional informations for patients and relatives.

Legislation

We inform about the legal and regulatory situation regarding medical cannabis and cannabinoids, in particular the planned revision of the Swiss narcotic law and newly approved appropriate preparations.

Congresses

Due to the current pandemic situation all congresses and training events planned for 2021 can so far only be performed in the online mode, e.g. as webinars.

Education

We are active in the education of health professionals, patients and other interested people, aiming to most efficiently and safely use cannabis and cannabinoids in medicine.

Scientific Journals

«Medical Cannabis and Cannabinoids» is the scientific journal of SGCM-SSCM. It is published by Karger in Basel allowing open access. The peer-reviewed journal offers an international forum for the presentation and discussion of research results covering the rapidly developing use of cannabis and cannabinoids in medicine.